Infobip and Oracle Collaborate to Build Global Omnichannel and Chatbot Integration
Integration extends Infobip’s partnership with Oracle, providing rich and conversational experiences for Oracle Fusion CloudResponsys Campaign Management customers
Global communications platform and Oracle PartnerNetwork member Infobip and global technology business Oracle are collaborating to build an integration between Infobip’s intelligent chatbot-building platform and omnichannel solutions and Oracle Fusion Cloud Responsys Campaign Management. The integration enables businesses and brands using Oracle Responsys Campaign Management to offer consumers rich conversational experiences and AI-driven chatbot services that enhance loyalty and boost sales.
As consumers seek a deeper connection with brands, rich conversational messaging channels such as chat apps and RCS are growing. For instance, some 4.9 billion business messaging users worldwide use rich messaging, 2.8 billion use WhatsApp, and 1.5 billion use RCS, according to Mobilesquared. However, to seize the opportunities of such channels, businesses need innovative services such as conversational AI and chatbots to provide tailored and conversational experiences for customers.
Businesses and brands using Oracle Responsys Campaign Management can now create conversational experiences and use intelligent chatbots to drive engagement through Oracle's integration of Infobip's channels like chat apps, social media messaging, RCS, and its chatbot-building platform. Infobip’s AI and GenAI chatbot-building platform Answers helps firms automate customer support and conversational marketing, facilitating smooth interactions throughout the customer journey while also helping reduce costs. With an unmatched portfolio of telecom partners globally, Infobip’s omnichannel solutions ensure messages are safely and securely delivered to customers anywhere.
Oracle Responsys Campaign Management is a cross-channel campaign management platform that delivers advanced intelligence at scale so firms can create personalized messages based on customers' and prospects' individual interests and preferences. It enables brands to build contextually relevant digital marketing campaigns for all consumers.
Stephen Streich, Group Vice President of Oracle Fusion Cloud Marketing, said: “Oracle delivers leading customer experience solutions that help organizations use data more intelligently to enhance engagement. Now, Oracle ResponsysCampaign Management customers can integrate with Infobip’s omnichannel solutions and intelligent chatbot-building platform to create compelling conversational campaigns that drive loyalty.”
Veselin Vukovic, VP of Strategic Partnerships at Infobip, said: “Infobip is already an Oracle Independent Software Vendor Partner with access to Oracle Integration Cloud, and this new addition further enhances our partnership with the global software company.”
About Infobip
Infobip is a global cloud communications platform that enables businesses to build connected experiences across all stages of the customer journey. Accessed through a single platform, Infobip’s omnichannel engagement, identity, user authentication and contact centre solutions help businesses and partners overcome the complexity of consumer communications to grow business and increase loyalty.
About Oracle Partner Network
Oracle PartnerNetwork (OPN) is Oracle's partner program designed to allow partners to accelerate the transition to new and promote superior business results for clients. The OPN program allows partners to become involved with Oracle through track(s) aligned to its market approach: Cloud Build for partners who provide products or services built or integrated with the Oracle Cloud; Cloud Sell for partners who resell Oracle Cloud technology; Cloud Service for partners who implement, implement and manage Oracle Cloud services; Industry Healthcare for partners who provide commercially available products and/or services built with Oracle Cloud and Oracle Health technologies; e License & Hardware for partners who build, service or sell software licenses or Oracle hardware products. Clients can accelerate their business objectives with OPN partners who achieve expertise in a family of products or services in new ways. To learn more, visit the site: http://www.oracle.com/partnernetwork.
Trademarks
Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first new company, inaugurating a new era of computing in the new world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241024751822/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Transition Industries Signs Strategic Agreements for the Pacifico Mexinol Project, the Largest Standalone Ultra-Low Carbon Chemical Production Facility in the World30.6.2025 20:30:00 CEST | Press release
Pacifico Mexinol project, a 6,130 MT per day ultra-low carbon methanol production facility worth more than US$3.3b will be located near Topolobampo, Ahome, Sinaloa. Once operational in 2029, Pacifico Mexinol is poised to be the largest standalone ultra-low carbon chemical production facility in the world. Transition Industries LLC, a developer of world-scale, net-zero carbon emissions methanol and green hydrogen projects in North America, held a signing event for an Engineering, Procurement, and Construction (EPC) contract with the consortium of Samsung E&A Co., Ltd. (Samsung E&A), Grupo Samsung E&A Mexico, S.A. de C.V., and Techint Engineering and Construction for the Pacifico Mexinol project located in Ahome, Sinaloa, Mexico, which is contingent upon the fulfillment of customary conditions precedent and obtainment of all required approvals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630940954/en/ MAIRE group’s techn
Westinghouse and ITER Sign a $180M Contract to Advance Nuclear Fusion30.6.2025 15:45:00 CEST | Press release
The contract includes the assembly of the fusion reactor’s vacuum vessel, a key milestone which gets the project closer to replicating fusion energy on Earth Westinghouse Electric Company and ITER signed a contract for $180 million for the assembly of the vacuum vessel for the fusion reactor. This is a key milestone in the construction of the ITER reactor, leading the way toward the use of fusion as a practical future source of reliable carbon-free energy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630497810/en/ The ITER Tokamak pit with the two vacuum vessel sector modules installed. Westinghouse has participated in the fabrication of the sectors of the vacuum vessel, as part of the Fusion for Energy (F4E) Consortium with its partners Ansaldo Nucleare and Walter Tosto. Westinghouse will be responsible for completing the vacuum vessel which is ITER’s most critical component: a hermetically sealed, double-walled steel
Monetate Acquires SiteSpect to Deliver AI-Native Personalization and Testing at Enterprise Scale30.6.2025 15:00:00 CEST | Press release
Monetate’s Real-Time Personalization Unites with SiteSpect’s Zero-Flicker Testing to Optimize Digital Experiences with Unmatched Speed, Precision, and SecurityNow Global Ecommerce and Digital Experience Leaders Can Access a Best-in-Class, Enterprise-Grade Personalization, Testing, and Optimization Platform Monetate, the leading AI-driven personalization platform, today announced it has acquired SiteSpect, a leader in A/B testing, to drive next-generation digital experience optimization. This acquisition accelerates Monetate’s vision to deliver intelligent, intentional, and individualized experiences at scale, powered by agentic AI and backed by the industry’s most advanced, enterprise-grade infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630514541/en/ The combination of Monetate’s real-time personalization and SiteSpect’s zero-flicker testing will yield an industry-first solution for enterprise-grade person
SS&C Blue Prism Recognized as a Gartner® Magic Quadrant™ RPA Leader for the Seventh Consecutive Year30.6.2025 15:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that SS&C Blue Prism has been recognized as a Leader in the 2025 Gartner Magic Quadrant for Robotic Process Automation (RPA). “We’re delighted SS&C Blue Prism has been named a Leader in the Gartner Magic Quadrant for Robotic Process Automation for the seventh year running,” said Bill Stone, CEO and Chairman of SS&C Technologies. “SS&C Blue Prism combines market-leading RPA and orchestration technologies with the latest artificial intelligence so organizations can tackle more complex tasks and dynamic business processes. We’ve scaled to more than 2,700 digital workers and AI agents across our own operations, resulting in over $200 million in annual savings. With SS&C leading the charge on deployment, customers can be confident in rolling out SS&C’s automation solutions securely, effectively, and responsibly.” More than 2,800 companies worldwide leverage SS&C Blue Prism for AI-powered automation, helping organizations delive
Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content130.6.2025 14:00:00 CEST | Press release
GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with Less Than or Equal to 2 µg/mL IgA in a 10% Solution is Approved for Intravenous or Subcutaneous Use in People Aged Two and Older with Primary Immunodeficiency1U.S. Commercialization of GAMMAGARD LIQUID ERC Projected to Begin in 2026Company Announces Future Manufacturing Discontinuation End Date for Takeda's First-Generation Low-IgA Product, A Freeze-Dried Formulation in Company’s Differentiated Immunoglobulin Portfolio of Ready-to-Use Liquids2 Takeda(TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC [immune globulin infusion (human)] with less than or equal to 2 µg/mL IgA in a 10% solution, the only ready-to-use liquid immunoglobulin (IG) therapy with low immunoglobulin A (IgA) content, as replacement therapy for people two years of age and older with primary immunodeficiency (PI). As a ready-to-use liquid, GAMMAGARD LIQUID ERC may help ease the administratio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom